📍 Local Job Near You
Advanced Practice Provider (NP/PA/CNS) Imaging APP: HCM, CAD, Valve and Aortic Disease I
Cleveland Clinic
📍
Cleveland, United States
Location
Cleveland
Posted
June 24, 2026
Commute
Local Area
Local Opportunity Near You!
This job is in your area. Enjoy a short commute and work close to home.
Job Description
***Competitive compensation + robust benefits package**
***Relocation for qualifying candidates**
***Sign-on Bonus currently being offered for qualifying candidates-** **_must be an experienced APRN/PA- minimum 3 years of Cardiology experience._**
The Cleveland Clinic Heart, Vascular & Thoracic Institute is seeking a highly motivated Advanced Practice Provider (APP) to become an integral part of our growing and unique practice model. The majority of the practice is comprised of patients with hypertrophic cardiomyopathy, aortic diseases, but also includes those with complex valve disease and coronary artery disease.
In addition to providing top-notch clinical care, the practice has a large presence within the research space. Some of their research studies have driven the introduction of new therapies for hypertrophic cardiomyopathy, which have now been adopted into clinical guidelines. They continue to pursue novel therapeutic targets in the pharmac...
***Relocation for qualifying candidates**
***Sign-on Bonus currently being offered for qualifying candidates-** **_must be an experienced APRN/PA- minimum 3 years of Cardiology experience._**
The Cleveland Clinic Heart, Vascular & Thoracic Institute is seeking a highly motivated Advanced Practice Provider (APP) to become an integral part of our growing and unique practice model. The majority of the practice is comprised of patients with hypertrophic cardiomyopathy, aortic diseases, but also includes those with complex valve disease and coronary artery disease.
In addition to providing top-notch clinical care, the practice has a large presence within the research space. Some of their research studies have driven the introduction of new therapies for hypertrophic cardiomyopathy, which have now been adopted into clinical guidelines. They continue to pursue novel therapeutic targets in the pharmac...